Insulin Pumps, Continuous Glucose Monitors, Closed Loop Insulin Delivery Systems and Associated Products

It is the intention for the following to be available under the terms of the Framework Agreement: Tethered Insulin Pumps, Patch Insulin Pumps, Continuous Glucose Monitoring (CGM) devices, Applications or software to enable the function of Closed Loop Insulin Delivery Systems and also for the dedicated consumables and accessories for the products listed above.

Due to technological advancement, specifications will be reviewed. To enable the NHS to access to the latest products via the framework, new suppliers may be awarded to the current Framework Agreement, which was launched in January 2022 and will run for an initial 24 month period, and may be extended up to a total of 48 months.

Precise quantities are unknown. It is anticipated that annual expenditure will be in the region of £15,000,000 - £20,000,000, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated total value over the 4 year agreement is approximately £75,000,000 to £100,000,000.